Pharmacological inhibition and genetic ablation of Ctbp2 are therefore both associated with reduction in polyposis, diminished intestinal TIC populations, and reduction in Wnt pathway oncogenic signaling in Apcmin intestine. Here, CTBP2 is linked to polyposis.